Search results
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 2 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 4 days agoSo, despite its revenue currently declining, AbbVie will be just fine. The pharmaceutical giant should be able to sustain its dividend program.
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 5 days agoLilly (NYSE: LLY), and Pfizer (NYSE: PFE) as dividend stocks to buy and hold for the next decade. An...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 1 day agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 3 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 2 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number ...
Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?
Zacks via Yahoo Finance· 20 hours agoIt's 12-month trailing dividend yield comes in at 1.71%. Sector Exposure and Top Holdings It is...
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks via Yahoo Finance· 2 days agoThe traditional retirement planning approaches no longer cover all expenses in nest egg years. So...
AbbVie announces LEVEL UP results in atopic dermatitis study By Investing.com
Investing.com· 7 days agoThe study focused on adult and adolescent patients who had an inadequate response to systemic...
BMO cuts Abbvie stock PT on lower revenue outlook for Vraylar, Humira concerns By Investing.com
Investing.com· 3 days agoOn Monday, BMO (TSX:BMO) Capital Markets adjusted its outlook onAbbvie (NYSE:ABBV), a...
